Results for tag: "Ganirelix"

Ganirelix is a drug used in the field of Sexual and Reproductive Health (SRH). It is a gonadotropin-releasing hormone (GnRH) antagonist, used to suppress the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This is used to prevent premature ovulation in women undergoing assisted reproductive technology (ART) treatments, such as in vitro fertilization (IVF). It is also used to treat endometriosis and uterine fibroids. Ganirelix is available in the form of an injection, and is typically administered by a healthcare professional. It is available in both brand-name and generic forms. The brand-name version is marketed by Merck & Co., Inc., while the generic version is available from several generic drug manufacturers. The SRH drugs market is a rapidly growing sector, with Ganirelix playing an important role in the treatment of infertility and other SRH conditions. It is widely used in ART treatments, and is increasingly being used to treat endometriosis and uterine fibroids. Some companies in the Ganirelix market include Merck & Co., Inc., Teva Pharmaceuticals, Mylan N.V., Sandoz International GmbH, and Sun Pharmaceutical Industries Ltd. Show Less Read more